Novo Holdings, the investment arm managing the Novo Nordisk Foundation's $36.2 billion portfolio, is accelerating its push into planetary health assets across multiple fronts. Partner Aleks Engel framed the urgency bluntly: "The planet is burning up, so we need to get on with doing something about it." The Copenhagen-based manager is targeting energy transition investments and larger deal tickets, moving beyond its traditional life sciences focus.

The firm is also evaluating a dedicated allocation for external private equity GPs to manage, a structural shift that would open its capital to outside managers for the first time in this strategy. This comes as Novo Holdings seeks to deploy capital at scale into decarbonization, sustainable agriculture, and circular economy projects — sectors requiring check sizes that often exceed its current direct investment capacity.

Geographic expansion is simultaneously underway, with Asia identified as a priority for new offices. The region's energy transition needs and manufacturing base align with the planetary health thesis, though regulatory complexity and local partnership requirements present execution risk.

For institutional investors, Novo Holdings' pivot signals growing LP appetite for climate-aligned private markets allocations backed by permanent capital. The GP allocation model could become a template for other sovereign-adjacent pools seeking specialization without building internal teams. Watch whether the Asia push materializes in 2025 — execution there will test whether the strategy scales beyond European deal flow.